Pluspunten
Autonomy (in field sales) Great *Legacy* Pharmaceutical Company Great Science on products which actually do make it through pipeline Slightly Above Average Compensation Good benefits Highly motivated senior management
Minpunten
Senior management: "Keep your resume updated" Morale in toilette with constant lay-offs Senior Strategy Exec: "We're shrinking" Declining career and industry growth prospects Dangerously low rate of innovation in R&D - new products revenues will not replace existing/expiring revenues Rather than producing more innovative, cost-effective drugs, the industry has simply increased prices to keep up with inflation sparking outrage. Poor strategy to reignite growth - not a single "big pharma" company in industry has mastered this. Consequently, inability to attract best and brightest because the industry's "golden age" is over